Literature DB >> 24907496

Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis.

Daniela Alves Fernandes1, Clarissa Lin Yasuda2, Tátila Martins Lopes1, Ghizoni Enrico3, Andréa Alessio1, Helder Tedeschi4, Evandro de Oliveira4, Fernando Cendes5.   

Abstract

OBJECTIVE: This study aimed to evaluate long-term atrophy in contralateral hippocampal volume after surgery for unilateral MTLE, as well as the cognitive outcome for patients submitted to either selective transsylvian amygdalohippocampectomy (SelAH) or anterior temporal lobe resection (ATL).
METHODS: We performed a longitudinal study of 47 patients with MRI signs of unilateral hippocampal sclerosis (23 patients with right-sided hippocampal sclerosis) who underwent surgical treatment for MTLE. They underwent preoperative/postoperative high-resolution MRI as well as neuropsychological assessment for memory and estimated IQ. To investigate possible changes in the contralateral hippocampus of patients, we included 28 controls who underwent two MRIs at long-term intervals.
RESULTS: The volumetry using preoperative MRI showed significant hippocampal atrophy ipsilateral to the side of surgery when compared with controls (p<0.0001) but no differences in contralateral hippocampal volumes. The mean postoperative follow-up was 8.7 years (± 2.5 SD; median=8.0). Our patients were classified as Engel I (80%), Engel II (18.2%), and Engel III (1.8%). We observed a small but significant reduction in the contralateral hippocampus of patients but no volume changes in controls. Most of the patients presented small declines in both estimated IQ and memory, which were more pronounced in patients with left TLE and in those with persistent seizures. Different surgical approaches did not impose differences in seizure control or in cognitive outcome.
CONCLUSIONS: We observed small declines in cognitive scores with most of these patients, which were worse in patients with left-sided resection and in those who continued to suffer from postoperative seizures. We also demonstrated that manual volumetry can reveal a reduction in volume in the contralateral hippocampus, although this change was mild and could not be detected by visual analysis. These new findings suggest that dynamic processes continue to act after the removal of the hippocampus, and further studies with larger groups may help in understanding the underlying mechanisms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognition; Contralateral hippocampus atrophy; Epilepsy surgery; Hippocampal sclerosis; MRI; MTLE; Memory outcome; Volumetry

Mesh:

Year:  2014        PMID: 24907496     DOI: 10.1016/j.yebeh.2014.04.028

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Characterization of postsurgical functional connectivity changes in temporal lobe epilepsy.

Authors:  Victoria L Morgan; Baxter P Rogers; Hernán F J González; Sarah E Goodale; Dario J Englot
Journal:  J Neurosurg       Date:  2019-06-14       Impact factor: 5.115

2.  Establishing Surface Correspondence for Post-surgical Cortical Thickness Changes in Temporal Lobe Epilepsy.

Authors:  Yue Liu; Dario J Englot; Victoria L Morgan; Warren D Taylor; Ying Wei; Ipek Oguz; Bennett A Landman; Ilwoo Lyu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2021-02-15

Review 3.  Systematic Review of Cognitive Function in Euthymic Bipolar Disorder and Pre-Surgical Temporal Lobe Epilepsy.

Authors:  Emmanuelle C S Bostock; Kenneth C Kirkby; Michael I Garry; Bruce V M Taylor
Journal:  Front Psychiatry       Date:  2017-08-09       Impact factor: 4.157

4.  Accuracy and practical aspects of semi- and fully automatic segmentation methods for resected brain areas.

Authors:  Karin Gau; Charlotte S M Schmidt; Horst Urbach; Josef Zentner; Andreas Schulze-Bonhage; Christoph P Kaller; Niels Alexander Foit
Journal:  Neuroradiology       Date:  2020-07-20       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.